Hydroflumethiazide: Difference between revisions
No edit summary |
No edit summary |
||
| Line 448: | Line 448: | ||
|brandNames= | |brandNames= | ||
* | * Saluron®<ref>{{Cite web | title = Saluron (hydroflumenthiazide) Tablet | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6153ef9e-77f0-4233-a5bc-3e3d1f732323 }}</ref> | ||
<!--Look-Alike Drug Names--> | <!--Look-Alike Drug Names--> | ||
| Line 454: | Line 454: | ||
|lookAlike= | |lookAlike= | ||
* | * N/A<ref name="www.ismp.org">{{Cite web | last = | first = | title = http://www.ismp.org | url = http://www.ismp.org | publisher = | date = }}</ref> | ||
<!--Drug Shortage Status--> | <!--Drug Shortage Status--> | ||
Revision as of 19:41, 6 July 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Gerald Chi
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
|
Title
See full prescribing information for complete Boxed Warning.
ConditionName:
|
Overview
Hydroflumethiazide is a thiazide-like diuretic that is FDA approved for the {{{indicationType}}} of . There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Condition1
- Dosing Information
- Dosage
Condition2
- Dosing Information
- Dosage
Condition3
- Dosing Information
- Dosage
Condition4
- Dosing Information
- Dosage
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Hydroflumethiazide in adult patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroflumethiazide in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Hydroflumethiazide in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Hydroflumethiazide in pediatric patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hydroflumethiazide in pediatric patients.
Contraindications
- Condition1
Warnings
|
Title
See full prescribing information for complete Boxed Warning.
ConditionName:
|
- Description
Precautions
- Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Hydroflumethiazide in the drug label.
Central Nervous System
Cardiovascular
Respiratory
Gastrointestinal
Hypersensitivity
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Hydroflumethiazide in the drug label.
Central Nervous System
Cardiovascular
Respiratory
Gastrointestinal
Hypersensitivity
Miscellaneous
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hydroflumethiazide in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Hydroflumethiazide during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Hydroflumethiazide with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Hydroflumethiazide with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Hydroflumethiazide with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Hydroflumethiazide with respect to specific gender populations.
Race
There is no FDA guidance on the use of Hydroflumethiazide with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Hydroflumethiazide in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Hydroflumethiazide in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Hydroflumethiazide in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Hydroflumethiazide in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Hydroflumethiazide in the drug label.
Condition1
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Hydroflumethiazide in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Hydroflumethiazide in the drug label.
Pharmacology
| |
Hydroflumethiazide
| |
| Systematic (IUPAC) name | |
| 1,1-Dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide | |
| Identifiers | |
| CAS number | |
| ATC code | C03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox |
| Mol. mass | 331.29 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Mechanism of Action
Structure
This image is provided by the National Library of Medicine.
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Hydroflumethiazide in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Hydroflumethiazide in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Hydroflumethiazide in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Hydroflumethiazide in the drug label.
Condition1
- Description
How Supplied
Storage
There is limited information regarding Hydroflumethiazide Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Hydroflumethiazide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Hydroflumethiazide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Hydroflumethiazide in the drug label.
Precautions with Alcohol
- Alcohol-Hydroflumethiazide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- Saluron®[1]
Look-Alike Drug Names
- N/A[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ "Saluron (hydroflumenthiazide) Tablet".
- ↑ "http://www.ismp.org". External link in
|title=(help)
{{#subobject:
|Page Name=Hydroflumethiazide |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage= |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Hydroflumethiazide |Label Name=Hydroflumethiazide11.png
}}
{{#subobject:
|Label Page=Hydroflumethiazide |Label Name=Hydroflumethiazide11.png
}}